Armistice Capital’s TC BioPharm (Holdings) plc Warrants TCBPW Stock Holding History

Armistice Capital’s Portfolio TCBPW Stock Details TCBPW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-188	Closed	-$2	–	290
2024 Q4	$2	Buy	+188	New	+$3	﹤0.01%	231
2024 Q1	–	Sell	-1,882,352	Closed	-$61	–	422
2023 Q4	$61	Buy	1,882,352 +1,844,705	+4,900%	+$43.2K	﹤0.01%	293
2023 Q3	$787	Hold	37,647	–	–	﹤0.01%	250
2023 Q2	$1.62K	Sell	37,647 -1	-0%	–	﹤0.01%	217
2023 Q1	$3.76K	Buy	37,648 +1	+0%	–	﹤0.01%	222
2022 Q4	$5.27K	Sell	37,647 -1,844,705	-98%	-$253K	﹤0.01%	191
2022 Q3	$435K	Hold	1,882,352	–	–	0.01%	151
2022 Q2	$381	Hold	1,882,352	–	–	0.01%	141
2022 Q1	$922K	Buy	+1,882,352	New	+$875K	0.02%	109

Armistice Capital's TCBPW Position: Q1 2025 in Review

Armistice Capital sold out of TC BioPharm (Holdings) plc Warrants (TCBPW) in Q1 2025, closing a stake of 188 shares — an estimated $2 sold.

Armistice Capital first reported a position in TCBPW in Q1 2022 and held it in 9 quarters. The position peaked at $922K in Q1 2022. 0 funds tracked by Wall St. Rank hold TCBPW as of Q1 2025.

Armistice Capital reported no remaining TC BioPharm (Holdings) plc Warrants position as of Q1 2025 after selling out during the quarter.
Armistice Capital sold 188 TC BioPharm (Holdings) plc Warrants shares in Q1 2025, an estimated $2.
Armistice Capital first reported a position in TC BioPharm (Holdings) plc Warrants in Q1 2022 and held it in 9 quarters.
Armistice Capital's TC BioPharm (Holdings) plc Warrants position peaked at $922K in Q1 2022.
0 funds tracked by Wall St. Rank held TC BioPharm (Holdings) plc Warrants as of Q1 2025.

Based on Armistice Capital's 13F filing for Q1 2025, filed 15 May 2025.